The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of riskRedox signaling, Nox5 and vascular remodeling in hypertensionVascular biology of ageing-Implications in hypertensionOxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signalingDownregulation of Nuclear Factor Erythroid 2-Related Factor and Associated Antioxidant Genes Contributes to Redox-Sensitive Vascular Dysfunction in HypertensionUrinary podocyte microparticles identify prealbuminuric diabetic glomerular injury.Hu antigen R is required for NOX-1 but not NOX-4 regulation by inflammatory stimuli in vascular smooth muscle cells.NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.Short daily versus conventional hemodialysis for hypertensive patients: a randomized cross-over study.The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of riskThe 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.An interaction of renin-angiotensin and kallikrein-kinin systems contributes to vascular hypertrophy in angiotensin II-induced hypertension: in vivo and in vitro studies.The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.Aldosterone signaling through transient receptor potential melastatin 7 cation channel (TRPM7) and its α-kinase domainNicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells.Adventitia-derived hydrogen peroxide impairs relaxation of the rat carotid artery via smooth muscle cell p38 mitogen-activated protein kinaseSpironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signalingMicroparticles induce cell cycle arrest through redox-sensitive processes in endothelial cells: implications in vascular senescence.Endothelial Gata5 transcription factor regulates blood pressure.Aldosterone Upregulates Transient Receptor Potential Melastatin 7 (TRPM7).Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical researchMolecular mechanisms of hypertension: role of Nox family NADPH oxidases.Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation.Receptor and nonreceptor tyrosine kinases in vascular biology of hypertension.Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression.Oxidative stress and hypertension: current concepts.Reactive oxygen species and vascular biology: implications in human hypertension.Vascular biology of magnesium and its transporters in hypertension.Cell signaling of angiotensin II on vascular tone: novel mechanisms.NOX isoforms and reactive oxygen species in vascular health.Angiotensin II and the vascular phenotype in hypertension.Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases.A new look at the renin-angiotensin system--focusing on the vascular system.Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells.Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies.Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies.Microparticles: biomarkers and beyond.
P50
Q24651499-504049A9-66FA-42BD-A7A4-AE074CF830B5Q26801400-8EEEBBAC-6B7F-44FF-8FA5-3857F2C70436Q28080862-EB0488C5-879E-4CB2-A37A-4A87326F6841Q28393242-5DC79171-F2AF-4A8B-82DB-77C520D8BE65Q28581557-4BE22CB8-4A27-49AD-A6C8-BFA3D9B3F577Q30581831-52BAFEFC-2F5A-4B18-8106-C4C79AD0B072Q30786020-0C3D3AC2-DB30-4AA5-96D5-CA79A8EA6B1BQ33632781-50A464A5-5379-4D21-9A54-1DA5E2E5DE65Q33660629-B05DF880-3054-419C-A34B-ED2E7727BF9DQ33686240-98436ED5-B9C5-4222-8F7D-1B59983B110BQ33916671-8DD2795C-BDA2-4EC0-9544-7F6BE8E27B79Q33916677-BCEE49E4-01C0-4DFD-A463-0DD1B508E165Q34450221-8A7D11AE-8EF3-4A68-BA8A-39734C3A5D95Q34607311-4EA41CED-3D94-41D2-B207-40D3DD7C784FQ34949485-1E2EBDAD-EBD3-4D75-963D-7B9B8CF47E8BQ35059397-1EA27CD0-6B88-4130-B15D-B207C0A76A52Q35151309-EAB4331E-10BE-40DF-A6C3-CCE0AB93B753Q36121902-03D5E769-1E06-4DA9-BF80-B4A1AA0372DEQ36366186-A40998ED-84EF-41B8-B11C-3BACD654CE0EQ36417731-FF0B419D-CF7C-4005-BFCE-768493C8A50DQ37260675-DC11A816-9C45-46C3-8AF2-4E5EDCC04C42Q37433974-A8383312-8C74-4C9D-B412-8116D4715525Q37476628-F1EBD414-9FCA-421E-A7B7-86A546E9CF06Q37619867-554DA397-9CFC-4D91-91DD-7F0DB19A9A5AQ37669066-6DB5CF8A-607C-432F-AECA-2044D5A47B8CQ37670311-9F73A7BA-D808-4D04-B47C-F133E7FC97D7Q37738029-7A0DFED3-5B14-4EAA-A8FE-66B486BD5DE7Q37803528-F53383A1-C83B-49E8-AA92-94FABAEFF25AQ37825707-2AC74DC6-E72A-4C27-B24A-EBAD1CAC036EQ37832995-010B95A5-BB31-45A4-9340-472739DB652DQ37858259-29CCC52F-E7E7-4B35-8F9D-857496E3C9DBQ37859447-D6C1188C-B0A7-4C6F-B744-69D98F52661CQ37924981-013F0917-36A8-4BB1-9D2E-636AEB376136Q37938442-DC73A6D3-B0EE-4200-9187-2AFDD32CC446Q37982904-C1B1AA5F-CCDA-4029-A0A4-5E0A4AB422C1Q37996665-3469A0C0-B7DA-48E4-9D94-1321CC95F78DQ38010883-EB439FDF-9052-492A-A818-A5A7B1B9E3EDQ38019841-3633E328-E9E7-488D-8022-0860979BD76FQ38019997-87950144-1489-4A6C-B52A-D70FD22F36ADQ38068236-C7438C4D-DBFE-4BDA-890D-204B809A3E7C
P50
description
South African medical researcher
@en
cardioloog
@nl
hulumtuese
@sq
ricercatrice
@it
հետազոտող
@hy
name
Rhian Touyz
@af
Rhian Touyz
@an
Rhian Touyz
@ast
Rhian Touyz
@bar
Rhian Touyz
@br
Rhian Touyz
@ca
Rhian Touyz
@co
Rhian Touyz
@cs
Rhian Touyz
@cy
Rhian Touyz
@da
type
label
Rhian Touyz
@af
Rhian Touyz
@an
Rhian Touyz
@ast
Rhian Touyz
@bar
Rhian Touyz
@br
Rhian Touyz
@ca
Rhian Touyz
@co
Rhian Touyz
@cs
Rhian Touyz
@cy
Rhian Touyz
@da
altLabel
Rhian Merry Touyz
@en
prefLabel
Rhian Touyz
@af
Rhian Touyz
@an
Rhian Touyz
@ast
Rhian Touyz
@bar
Rhian Touyz
@br
Rhian Touyz
@ca
Rhian Touyz
@co
Rhian Touyz
@cs
Rhian Touyz
@cy
Rhian Touyz
@da
P166
P1015
P214
P244
P269
P1015
P166
P19
P1960
JNxRLrQAAAAJ
P21
P214
P244
no2012032958
P269
P31
P39
P4789
P496
0000-0003-0670-0887
P5008
P551
P569
1959-01-27T00:00:00Z